Gahanna, OH, United States of America

Clifford J Beall

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Nationwide Children's Hospital. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Clifford J Beall. Retrieved from https://idiyas.com/inventor/clifford-j-beall

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Clifford J Beall

Introduction

Clifford J Beall is an accomplished inventor based in Gahanna, OH (US). He has made significant contributions to the field of recombinant adeno-associated virus production. His work is particularly relevant in the context of gene therapy and biotechnology.

Latest Patents

Clifford J Beall holds a patent for the "Production of rAAV in vero cells using particular adenovirus helpers." This invention relates to methods and materials for producing recombinant adeno-associated virus (rAAV). Specifically, it involves the use of an adenovirus known as Simian Adenovirus 13 (SAdV-13) and Vero cells for the production process. He has 1 patent to his name.

Career Highlights

Beall is associated with Nationwide Children's Hospital, Inc., where he applies his expertise in the field of virology and gene therapy. His work has the potential to impact various medical applications, particularly in treating genetic disorders.

Collaborations

He has collaborated with notable colleagues, including Kelly Reed Clark and Philip R Johnson, Jr. These partnerships enhance the research and development efforts in his field.

Conclusion

Clifford J Beall's innovative work in recombinant adeno-associated virus production showcases his dedication to advancing medical science. His contributions are vital for future developments in gene therapy and biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…